Surgical Innovations Group Plc (SUN) Earns “Buy” Rating from N+1 Singer
Surgical Innovations Group Plc (LON:SUN)‘s stock had its “buy” rating restated by investment analysts at N+1 Singer in a report released on Monday. They presently have a GBX 5.50 ($0.07) price target on the stock. N+1 Singer’s target price would indicate a potential upside of 35.80% from the company’s previous close.
Shares of Surgical Innovations Group Plc (LON:SUN) opened at 4.05 on Monday. Surgical Innovations Group Plc has a 12-month low of GBX 1.75 and a 12-month high of GBX 4.42. The stock has a 50 day moving average of GBX 3.70 and a 200 day moving average of GBX 3.62. The company’s market cap is GBX 21.60 million.
In related news, insider Paul Hardy purchased 815,721 shares of the company’s stock in a transaction that occurred on Thursday, July 27th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £24,471.63 ($32,280.21).
About Surgical Innovations Group Plc
Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships.
Receive News & Ratings for Surgical Innovations Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Innovations Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.